BROOKFIELD ASSET MANAGEMENT LTD. (BAM): what the price requires

The current priced-in claim for BROOKFIELD ASSET MANAGEMENT LTD. (BAM) is temporarily suppressed because the live engine record is unavailable. The dated report remains a snapshot, not a current market read.

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/BAM

Headline

FieldValue
TickerBAM
CompanyBROOKFIELD ASSET MANAGEMENT LTD.
Current price$46.48/sh
CompositionInfrastructure 20% / Renewable Power and Transition 14% / Private Equity 9% / Real Estate 22% / Credit 34%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfee-financial
Price-to-earnings8.5x
Earnings yield11.8%

The price sits below what even a 5%/yr fee-earnings decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 11.5% cost of equity with 4% terminal growth over a 5-year stage, on a 5-year median GAAP earnings base.

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
cohort percentile (of 49 peers)6
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.45x3justifies
Earnings0.82x2justifies
Relative1.21x2expensive
Growth0.41x4justifies

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.6%); the inversion above states its own rate.

Per-Model Detail (n=11)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$227.760.20xyesFCF base $2.5B, growth 21% (input: historical growth), terminal g 4.0%, WACC 8.6%, 6yr projection
DCF Exit MultipleGrowth$89.190.52xyesExit EV/EBITDA: 404.7x / 406.7x / 408.7x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelative$38.391.21xyesP/S fallback (negative EPS): Sector P/S 3.0x × TTM revenue — excluded from consensus
Simple DDMGrowthno
Two-Stage DDMGrowth$156.750.30xyesStage 1: 5% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$67.540.69xyesBV/sh $21.65, ROE (TTM) 28.8%, ke 9.3%
Two-Stage Excess ReturnAsset$122.250.38xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$54.380.85xyesRev $5.1B, growth 21% (input: historical growth; tapered), Terminal P/S: 3.0x / 3.6x / 4.3x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$0.00noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowthno
Earnings Power ValueEarningsno
Residual IncomeAsset$102.350.45xyesBV $21.65 + 5yr PV of (ROE (TTM) 28.8% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAssetno
EV/EBITDA RelativeRelativeno
FCF YieldEarnings$58.390.80xyesFCF $2318.0M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$54.990.85xyesSBC-adj FCF $2.19B (FCF $2.32B − SBC $0.13B) capitalized at Kₑ
Ben Graham FormulaEarningsno
ROIC-Justified P/BAssetno
P/Sales SectorRelative$38.391.21xyesRevenue $5.07B × sector P/S 3.0x
PEG Fair ValueRelativeno
Earnings YieldEarningsno
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net debt$1.9b
Net debt / NOPAT (after-tax)0.84x
Net debt / operating income (pre-tax)0.70x
Burning cashno

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

Bull Case

The clearest way to see the bull case is to look at how far the price sits below where the methods land. The cash-flow and excess-return lenses, anchored on Brookfield's fee earnings and its high return on equity near 29%, all point well above the current price, with the growth-oriented and return-based methods landing at a large premium to today's level. A fee-based asset manager is worth the stream of fees it collects, and on that basis the price reads cheap: at roughly 9 times earnings, an earnings yield above 11%, Brookfield trades in the lower half of the alternative-manager group despite a faster-growing fee base than most of it.

What makes the fees worth paying up for is their stickiness. Brookfield manages capital across five real-asset verticals, and the filing states that of its fee-bearing capital "87% is long-dated or perpetual in nature, providing resiliency". That single fact reshapes the business: most asset managers live in fear of redemptions, but Brookfield's investors are locked into multi-year and permanent vehicles, so the management-fee stream is closer to a subscription than to a market-sensitive trading book. Fee-bearing capital grew $64 billion, or 12%, to over $600 billion in 2025, and fee-related earnings, the cleanest measure of the core business, rose 11% in the first quarter of 2026 to $772 million, with distributable earnings of $702 million.

The growth runway is the third leg. Brookfield raised $112 billion in 2025, is guiding 2026 to a record fundraising year supported by flagship fund launches and the full integration of Oaktree, and has set a target of $1.1 trillion of fee-bearing capital by 2029, which would extend its mid-teens growth rate for years. The business is also capital-light: it earns fees on other people's money, carries modest net debt around 0.7 times operating income, and just raised its dividend 15%. A franchise compounding a perpetual fee base at low-double-digit rates, throwing off rising distributions, and trading at single-digit earnings is the kind of mismatch the bull case is built on. The bet is that the secular shift of institutional capital into private real assets continues, and Brookfield is one of the handful of managers large enough to absorb the biggest mandates.

Bear Case

The competitive pressure in alternative asset management is intensifying, and Brookfield is not immune to it. The business depends entirely on convincing institutions to keep handing it capital, and the filing is explicit that this is a performance race: "performance enhances our ability to compete for investors. Our investors and potential investors continually assess investment performance and our ability to raise capital for existing and future funds depends on our funds' relative and ab"solute returns. In plain terms, the fee engine runs on a reputation that has to be re-earned with every fund vintage. The largest alternative managers, including the firm's biggest scaled peer, are chasing the same pension and sovereign-wealth dollars, and as the category matures, fee rates face downward pressure and the marginal mandate gets harder to win.

The asset classes themselves carry cyclical risk that the perpetual-capital framing can obscure. Brookfield's verticals are infrastructure, renewables, private equity, real estate, and credit, and several of those are sensitive to interest rates and the economic cycle. The filing acknowledges that "Any prolonged economic expansion or recession could have an adverse impact on certain credit strategies" and on the ability to deliver the returns that generate performance fees. Real estate in particular has been under pressure across the industry, and a stretch of weak fund performance does two things at once: it dampens the incentive and performance fees that boost earnings, and it makes the next fundraising round harder, which slows the fee-bearing capital growth the whole valuation rests on.

The valuation also has a structural quirk a holder should understand. The publicly traded Brookfield Asset Management entity holds a partial economic interest in the underlying asset-management business, so its reported GAAP figures do not map cleanly to the full franchise, and the fee metrics management emphasizes are the more meaningful read than the headline GAAP earnings. The price already discounts something: it sits in the lower half of the peer group's earnings multiple, which suggests the market is skeptical that the mid-teens fee growth and the record-fundraising guidance fully come through. If fundraising slows, if performance in one of the large verticals disappoints, or if fee compression accelerates as the category crowds, the growth that justifies the premium-quality fee stream fades, and a manager priced for durable double-digit fee growth re-rates toward the slower-growing peers it currently trades alongside. The bear case is not that the fees vanish. It is that the growth rate the bull case assumes is contested by a maturing, more competitive market.

Valuation

A capital-light fee business is worth the fee earnings it throws off, not its book value, so Brookfield is read off its earnings multiple rather than an asset-based one. At roughly 9 times earnings, an earnings yield above 11%, the price sits below what even a 5% annual decline in fee earnings would warrant. That is a low bar for a business whose fee-related earnings are growing at a double-digit rate, which is the core of the value case: the price is paying for stagnation or decline, while the business is compounding.

The method disagreement runs heavily in the cheap direction, but it has to be read with care. The growth cash-flow, two-stage return, and residual-income lenses all land far above the price, reflecting Brookfield's high return on equity near 29% and its fee growth. Some of the engine's other models misfire on Brookfield's partial-interest GAAP structure (an EV/EBITDA reading and a revenue-multiple fallback that the negative reported EPS triggers are not meaningful for this entity), so the honest read leans on the fee-earnings and return-based methods, which agree the price is well below intrinsic fee value. The cleanest framing is the earnings yield itself: above 11% on a growing, mostly perpetual fee stream is a wide gap to the cost of equity, and that gap is the margin the buyer is being offered for the risk that the growth slows.

Solvency is not the concern here, because the business does not run on leverage. Net debt is modest at roughly 0.7 times operating income, and the company earns its money managing other people's capital rather than deploying its own balance sheet, so the downside is about fee growth and performance, not financial distress. The dividend was just raised 15%, which signals management's confidence in the fee stream's durability. The most decisive point for the valuation is the spread between price and fee value: at single-digit earnings with double-digit fee growth and a perpetual-heavy capital base, the buyer is paid to wait, and the central question is simply whether the record-fundraising guidance and the $1.1 trillion 2029 target keep the fee base compounding at the pace the discount implies it will not.

Catalysts

Brookfield closed 2025 with record results and carried the momentum into 2026. The firm raised $112 billion of capital in 2025, grew fee-related earnings 22% and distributable earnings 14% for the year, and raised its dividend 15%, with management calling for 2026 to exceed its long-term growth targets. Fee-bearing capital, the base that generates the management fees, increased 12% over the trailing year to $614 billion as of the first quarter of 2026.

The most-watched catalyst is fundraising, because it is the leading indicator of future fees. Management expects 2026 to be a record fundraising year, supported by large capital mandates, flagship fund launches, and the pending full integration of Oaktree, the credit manager that broadens Brookfield's reach into private debt. The firm has set a target of $1.1 trillion of fee-bearing capital by 2029, implying it expects to beat its 16% compound growth goal. Each fund close and each quarter's fee-bearing capital figure is a discrete read on whether that trajectory holds.

The near-term financial signal is the quarterly fee-related and distributable earnings progression. Fee-related earnings rose 11% to $772 million and distributable earnings reached $702 million in the first quarter, and the board declared a quarterly dividend of $0.5025 per share payable at the end of June. The next reports, with the fundraising tally and the fee-related earnings growth rate, are the cleanest evidence of whether 2026 delivers the record year management has guided to.

Peer Cohorts (Per Segment, With Filing Citations)

Infrastructure (reported)

Renewable Power and Transition / Private Equity +2 more (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Brookfield Q1 2026 results · Brookfield 2025 results and 2026 outlook · Brookfield FY2025 10-K · Brookfield 2025 results · Brookfield 2026 outlook

View the full interactive BAM report on boothcheck